CN108651634A - A kind of formula milk and preparation method thereof being suitble to 0 to 6 months babies - Google Patents
A kind of formula milk and preparation method thereof being suitble to 0 to 6 months babies Download PDFInfo
- Publication number
- CN108651634A CN108651634A CN201810370460.1A CN201810370460A CN108651634A CN 108651634 A CN108651634 A CN 108651634A CN 201810370460 A CN201810370460 A CN 201810370460A CN 108651634 A CN108651634 A CN 108651634A
- Authority
- CN
- China
- Prior art keywords
- milk powder
- babies
- acid
- raw material
- formula milk
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013350 formula milk Nutrition 0.000 title claims abstract description 65
- 238000002360 preparation method Methods 0.000 title claims description 22
- 239000000843 powder Substances 0.000 claims abstract description 125
- 239000002994 raw material Substances 0.000 claims abstract description 43
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims abstract description 28
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 28
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims abstract description 26
- 239000011782 vitamin Substances 0.000 claims abstract description 24
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 23
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 23
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 23
- 239000011575 calcium Substances 0.000 claims abstract description 23
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 23
- 229940088594 vitamin Drugs 0.000 claims abstract description 23
- 229930003231 vitamin Natural products 0.000 claims abstract description 23
- 235000013343 vitamin Nutrition 0.000 claims abstract description 23
- 239000003921 oil Substances 0.000 claims abstract description 21
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 21
- 229960001231 choline Drugs 0.000 claims abstract description 18
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 18
- 239000011707 mineral Substances 0.000 claims abstract description 18
- 239000002773 nucleotide Substances 0.000 claims abstract description 17
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 17
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229960000367 inositol Drugs 0.000 claims abstract description 16
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims abstract description 16
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000005862 Whey Substances 0.000 claims abstract description 15
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims abstract description 15
- 150000003271 galactooligosaccharides Chemical class 0.000 claims abstract description 15
- 235000021342 arachidonic acid Nutrition 0.000 claims abstract description 14
- 229940114079 arachidonic acid Drugs 0.000 claims abstract description 14
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims abstract description 14
- 239000004519 grease Substances 0.000 claims abstract description 14
- 229960003080 taurine Drugs 0.000 claims abstract description 14
- 229940090949 docosahexaenoic acid Drugs 0.000 claims abstract description 13
- 239000010773 plant oil Substances 0.000 claims abstract description 13
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 12
- 239000008101 lactose Substances 0.000 claims abstract description 12
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims abstract description 11
- 108010079058 casein hydrolysate Proteins 0.000 claims abstract description 11
- 235000020778 linoleic acid Nutrition 0.000 claims abstract description 11
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims abstract description 11
- 235000020183 skimmed milk Nutrition 0.000 claims abstract description 9
- 239000012141 concentrate Substances 0.000 claims abstract description 8
- 235000021119 whey protein Nutrition 0.000 claims abstract description 8
- 239000000463 material Substances 0.000 claims description 36
- 235000013336 milk Nutrition 0.000 claims description 36
- 239000008267 milk Substances 0.000 claims description 36
- 210000004080 milk Anatomy 0.000 claims description 36
- 238000003860 storage Methods 0.000 claims description 34
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 33
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 30
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 24
- 239000000203 mixture Substances 0.000 claims description 23
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 claims description 22
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 20
- 235000019198 oils Nutrition 0.000 claims description 20
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 18
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 18
- 229960003512 nicotinic acid Drugs 0.000 claims description 18
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 claims description 17
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 17
- 235000010755 mineral Nutrition 0.000 claims description 17
- 238000012216 screening Methods 0.000 claims description 17
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 16
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 16
- 235000001968 nicotinic acid Nutrition 0.000 claims description 16
- 239000011664 nicotinic acid Substances 0.000 claims description 16
- 229940055726 pantothenic acid Drugs 0.000 claims description 15
- 235000019161 pantothenic acid Nutrition 0.000 claims description 15
- 239000011713 pantothenic acid Substances 0.000 claims description 15
- 239000011734 sodium Substances 0.000 claims description 15
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 14
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 14
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 14
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 14
- 230000015572 biosynthetic process Effects 0.000 claims description 14
- 229940099596 manganese sulfate Drugs 0.000 claims description 14
- 239000011702 manganese sulphate Substances 0.000 claims description 14
- 235000007079 manganese sulphate Nutrition 0.000 claims description 14
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims description 14
- 229910052708 sodium Inorganic materials 0.000 claims description 14
- 239000002253 acid Substances 0.000 claims description 12
- 238000011049 filling Methods 0.000 claims description 12
- 229960003966 nicotinamide Drugs 0.000 claims description 12
- 235000005152 nicotinamide Nutrition 0.000 claims description 12
- 239000011570 nicotinamide Substances 0.000 claims description 12
- 238000007873 sieving Methods 0.000 claims description 12
- 239000011780 sodium chloride Substances 0.000 claims description 12
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 12
- 239000002126 C01EB10 - Adenosine Substances 0.000 claims description 11
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 11
- 229960005305 adenosine Drugs 0.000 claims description 11
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims description 11
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 claims description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 10
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 10
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 claims description 10
- 235000019700 dicalcium phosphate Nutrition 0.000 claims description 10
- 229960000342 retinol acetate Drugs 0.000 claims description 10
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 claims description 10
- 235000019173 retinyl acetate Nutrition 0.000 claims description 10
- 239000011770 retinyl acetate Substances 0.000 claims description 10
- 235000019190 thiamine hydrochloride Nutrition 0.000 claims description 10
- 239000011747 thiamine hydrochloride Substances 0.000 claims description 10
- 229960000344 thiamine hydrochloride Drugs 0.000 claims description 10
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 10
- 235000005282 vitamin D3 Nutrition 0.000 claims description 10
- 239000011647 vitamin D3 Substances 0.000 claims description 10
- 229940021056 vitamin d3 Drugs 0.000 claims description 10
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 claims description 9
- 235000019743 Choline chloride Nutrition 0.000 claims description 9
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 9
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 claims description 9
- 229960003178 choline chloride Drugs 0.000 claims description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 9
- KURVIXMFFSNONZ-WFIJOQBCSA-L disodium;[(2r,3s,4r,5r)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound [Na+].[Na+].O[C@@H]1[C@H](O)[C@@H](COP([O-])([O-])=O)O[C@H]1N1C(=O)NC(=O)C=C1 KURVIXMFFSNONZ-WFIJOQBCSA-L 0.000 claims description 9
- 239000011706 ferric diphosphate Substances 0.000 claims description 9
- 235000007144 ferric diphosphate Nutrition 0.000 claims description 9
- CADNYOZXMIKYPR-UHFFFAOYSA-B ferric pyrophosphate Chemical compound [Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O CADNYOZXMIKYPR-UHFFFAOYSA-B 0.000 claims description 9
- 229940036404 ferric pyrophosphate Drugs 0.000 claims description 9
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 9
- 238000012856 packing Methods 0.000 claims description 9
- 229960002477 riboflavin Drugs 0.000 claims description 9
- 235000012424 soybean oil Nutrition 0.000 claims description 9
- 239000003549 soybean oil Substances 0.000 claims description 9
- 230000001954 sterilising effect Effects 0.000 claims description 9
- 235000020238 sunflower seed Nutrition 0.000 claims description 9
- 238000005303 weighing Methods 0.000 claims description 9
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 8
- 229960000304 folic acid Drugs 0.000 claims description 8
- 235000019152 folic acid Nutrition 0.000 claims description 8
- 239000011724 folic acid Substances 0.000 claims description 8
- 235000019192 riboflavin Nutrition 0.000 claims description 8
- 239000002151 riboflavin Substances 0.000 claims description 8
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 8
- 235000013311 vegetables Nutrition 0.000 claims description 8
- 235000000638 D-biotin Nutrition 0.000 claims description 7
- 239000011665 D-biotin Substances 0.000 claims description 7
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 7
- 229910052742 iron Inorganic materials 0.000 claims description 7
- 239000001103 potassium chloride Substances 0.000 claims description 7
- 235000011164 potassium chloride Nutrition 0.000 claims description 7
- 239000011781 sodium selenite Substances 0.000 claims description 7
- 235000015921 sodium selenite Nutrition 0.000 claims description 7
- 229960001471 sodium selenite Drugs 0.000 claims description 7
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 7
- 239000011627 DL-alpha-tocopherol Substances 0.000 claims description 6
- 238000004140 cleaning Methods 0.000 claims description 6
- 229910052751 metal Inorganic materials 0.000 claims description 6
- 239000002184 metal Substances 0.000 claims description 6
- 150000002739 metals Chemical class 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- 229960000984 tocofersolan Drugs 0.000 claims description 6
- 239000011787 zinc oxide Substances 0.000 claims description 5
- -1 chlorine Cobalt amine Chemical class 0.000 claims description 4
- 238000007689 inspection Methods 0.000 claims description 4
- GRSZFWQUAKGDAV-KQYNXXCUSA-N IMP Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(NC=NC2=O)=C2N=C1 GRSZFWQUAKGDAV-KQYNXXCUSA-N 0.000 claims description 3
- GRSZFWQUAKGDAV-UHFFFAOYSA-N Inosinic acid Natural products OC1C(O)C(COP(O)(O)=O)OC1N1C(NC=NC2=O)=C2N=C1 GRSZFWQUAKGDAV-UHFFFAOYSA-N 0.000 claims description 3
- 235000013902 inosinic acid Nutrition 0.000 claims description 3
- 238000002955 isolation Methods 0.000 claims description 3
- 238000002372 labelling Methods 0.000 claims description 3
- 238000011068 loading method Methods 0.000 claims description 3
- 230000001681 protective effect Effects 0.000 claims description 3
- 238000005070 sampling Methods 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 238000012360 testing method Methods 0.000 claims description 3
- 239000000284 extract Substances 0.000 claims description 2
- 238000010521 absorption reaction Methods 0.000 abstract description 16
- 230000012010 growth Effects 0.000 abstract description 12
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 8
- 235000020661 alpha-linolenic acid Nutrition 0.000 abstract description 5
- 229960004488 linolenic acid Drugs 0.000 abstract description 5
- 230000029087 digestion Effects 0.000 abstract description 4
- 230000036737 immune function Effects 0.000 abstract description 4
- 210000000936 intestine Anatomy 0.000 abstract description 4
- 230000008855 peristalsis Effects 0.000 abstract description 3
- 235000013305 food Nutrition 0.000 description 17
- 239000000047 product Substances 0.000 description 17
- 235000020256 human milk Nutrition 0.000 description 15
- 210000004251 human milk Anatomy 0.000 description 15
- 230000006870 function Effects 0.000 description 13
- 235000018102 proteins Nutrition 0.000 description 13
- 102000004169 proteins and genes Human genes 0.000 description 13
- 108090000623 proteins and genes Proteins 0.000 description 13
- 235000019197 fats Nutrition 0.000 description 11
- 210000004556 brain Anatomy 0.000 description 10
- 238000011161 development Methods 0.000 description 10
- 230000018109 developmental process Effects 0.000 description 10
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 9
- BYLXFSREGROOBJ-UVKKECPRSA-K cobalt(3+) [(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate chloride Chemical compound [Cl-].[Co+3].C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)C2[N-]\C1=C(C)/C1=N/C(=C\C3=N\C(=C(C)/C4=N[C@]2(C)[C@@](C)(CC(N)=O)[C@@H]4CCC(N)=O)\[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)/C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)n1cnc2cc(C)c(C)cc12 BYLXFSREGROOBJ-UVKKECPRSA-K 0.000 description 9
- IERHLVCPSMICTF-XVFCMESISA-N cytidine 5'-monophosphate Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(O)=O)O1 IERHLVCPSMICTF-XVFCMESISA-N 0.000 description 9
- IERHLVCPSMICTF-UHFFFAOYSA-N cytidine monophosphate Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(COP(O)(O)=O)O1 IERHLVCPSMICTF-UHFFFAOYSA-N 0.000 description 9
- 230000000968 intestinal effect Effects 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 9
- 229910052698 phosphorus Inorganic materials 0.000 description 9
- 239000011574 phosphorus Substances 0.000 description 9
- SLIUELDPAPMQIB-IDIVVRGQSA-N [Na].[Na].[C@@H]1([C@H](O)[C@H](O)[C@@H](COP(=O)(O)O)O1)N1C=NC=2C(O)=NC=NC12 Chemical compound [Na].[Na].[C@@H]1([C@H](O)[C@H](O)[C@@H](COP(=O)(O)O)O1)N1C=NC=2C(O)=NC=NC12 SLIUELDPAPMQIB-IDIVVRGQSA-N 0.000 description 7
- 230000004060 metabolic process Effects 0.000 description 7
- 230000009286 beneficial effect Effects 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 238000001727 in vivo Methods 0.000 description 6
- 210000002569 neuron Anatomy 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 239000013589 supplement Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 238000005660 chlorination reaction Methods 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 4
- 229960004373 acetylcholine Drugs 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 239000003792 electrolyte Substances 0.000 description 4
- 210000003722 extracellular fluid Anatomy 0.000 description 4
- 244000144972 livestock Species 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 210000001525 retina Anatomy 0.000 description 4
- 102000009027 Albumins Human genes 0.000 description 3
- 108010088751 Albumins Proteins 0.000 description 3
- 108010076119 Caseins Proteins 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 102000004407 Lactalbumin Human genes 0.000 description 3
- 108090000942 Lactalbumin Proteins 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 210000004958 brain cell Anatomy 0.000 description 3
- 230000004641 brain development Effects 0.000 description 3
- 239000005018 casein Substances 0.000 description 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 3
- 235000021240 caseins Nutrition 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 230000004663 cell proliferation Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 238000005238 degreasing Methods 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 239000002778 food additive Substances 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000007413 intestinal health Effects 0.000 description 3
- 230000008604 lipoprotein metabolism Effects 0.000 description 3
- 230000003908 liver function Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000007830 nerve conduction Effects 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 244000144977 poultry Species 0.000 description 3
- 239000006041 probiotic Substances 0.000 description 3
- 235000018291 probiotics Nutrition 0.000 description 3
- SCWQRZHMKQEINE-UHFFFAOYSA-N selenous acid;sodium Chemical compound [Na].O[Se](O)=O SCWQRZHMKQEINE-UHFFFAOYSA-N 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 210000000225 synapse Anatomy 0.000 description 3
- 230000004382 visual function Effects 0.000 description 3
- 235000019156 vitamin B Nutrition 0.000 description 3
- 239000011720 vitamin B Substances 0.000 description 3
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 2
- LFDGRWDETVOGDT-UHFFFAOYSA-N 1h-pyrrole;hydrochloride Chemical compound Cl.C=1C=CNC=1 LFDGRWDETVOGDT-UHFFFAOYSA-N 0.000 description 2
- 206010006956 Calcium deficiency Diseases 0.000 description 2
- 241000370738 Chlorion Species 0.000 description 2
- 206010014418 Electrolyte imbalance Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 235000002918 Fraxinus excelsior Nutrition 0.000 description 2
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 239000005864 Sulphur Substances 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- 229930003537 Vitamin B3 Natural products 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 2
- 239000003674 animal food additive Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000002956 ash Substances 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 2
- 230000003185 calcium uptake Effects 0.000 description 2
- MWKXCSMICWVRGW-UHFFFAOYSA-N calcium;phosphane Chemical compound P.[Ca] MWKXCSMICWVRGW-UHFFFAOYSA-N 0.000 description 2
- 229960004203 carnitine Drugs 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 208000007287 cheilitis Diseases 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 229940063755 folic acid 0.1 mg Drugs 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 239000002777 nucleoside Substances 0.000 description 2
- 125000003835 nucleoside group Chemical group 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000009965 odorless effect Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229940052714 riboflavin 1 mg Drugs 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 229910001415 sodium ion Inorganic materials 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 235000021081 unsaturated fats Nutrition 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 235000019160 vitamin B3 Nutrition 0.000 description 2
- 239000011708 vitamin B3 Substances 0.000 description 2
- 235000019158 vitamin B6 Nutrition 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- 229940046001 vitamin b complex Drugs 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 229940003613 zinc oxide 10 mg Drugs 0.000 description 2
- 229940116992 zinc oxide 8 mg Drugs 0.000 description 2
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 206010002064 Anaemia macrocytic Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 239000005739 Bordeaux mixture Substances 0.000 description 1
- 102000004031 Carboxy-Lyases Human genes 0.000 description 1
- 108090000489 Carboxy-Lyases Proteins 0.000 description 1
- 206010058892 Carnitine deficiency Diseases 0.000 description 1
- 206010008803 Chromoblastomycosis Diseases 0.000 description 1
- 208000015116 Chromomycosis Diseases 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 239000005749 Copper compound Substances 0.000 description 1
- 208000027219 Deficiency disease Diseases 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- AANLCWYVVNBGEE-IDIVVRGQSA-L Disodium inosinate Chemical group [Na+].[Na+].O[C@@H]1[C@H](O)[C@@H](COP([O-])([O-])=O)O[C@H]1N1C(NC=NC2=O)=C2N=C1 AANLCWYVVNBGEE-IDIVVRGQSA-L 0.000 description 1
- 235000021294 Docosapentaenoic acid Nutrition 0.000 description 1
- 206010015226 Erythema nodosum Diseases 0.000 description 1
- 208000001034 Frostbite Diseases 0.000 description 1
- 208000005232 Glossitis Diseases 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010021929 Infertility male Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000007466 Male Infertility Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 description 1
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 1
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 1
- 206010029240 Neuritis Diseases 0.000 description 1
- 206010029491 Nodular vasculitis Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 102000004879 Racemases and epimerases Human genes 0.000 description 1
- 108090001066 Racemases and epimerases Proteins 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010039921 Selenium deficiency Diseases 0.000 description 1
- 208000006981 Skin Abnormalities Diseases 0.000 description 1
- 206010041736 Sporotrichosis Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- DJJCXFVJDGTHFX-UHFFFAOYSA-N Uridinemonophosphate Natural products OC1C(O)C(COP(O)(O)=O)OC1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-UHFFFAOYSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 208000007642 Vitamin B Deficiency Diseases 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003571 Vitamin B5 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010047634 Vitamin K deficiency Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000012271 agricultural production Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical group OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 201000003465 angular cheilitis Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 235000008452 baby food Nutrition 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 235000011116 calcium hydroxide Nutrition 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000012611 container material Substances 0.000 description 1
- 150000001880 copper compounds Chemical class 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 235000011950 custard Nutrition 0.000 description 1
- 208000029039 cyanide poisoning Diseases 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- 235000013890 disodium inosinate Nutrition 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 201000008496 endemic goiter Diseases 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 235000015168 fish fingers Nutrition 0.000 description 1
- 239000003063 flame retardant Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000010855 food raising agent Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000031169 hemorrhagic disease Diseases 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 238000005213 imbibition Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000011499 joint compound Substances 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 201000006437 macrocytic anemia Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 150000002696 manganese Chemical class 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229910001511 metal iodide Inorganic materials 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 235000021243 milk fat Nutrition 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 235000019175 phylloquinone Nutrition 0.000 description 1
- 239000011772 phylloquinone Substances 0.000 description 1
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 1
- 229960001898 phytomenadione Drugs 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 239000011819 refractory material Substances 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 239000000565 sealant Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229940091258 selenium supplement Drugs 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000019100 sperm motility Effects 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 208000016505 systemic primary carnitine deficiency disease Diseases 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 150000003544 thiamines Chemical class 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- DJJCXFVJDGTHFX-XVFCMESISA-N uridine 5'-monophosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-XVFCMESISA-N 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 235000021468 vitamin B8 Nutrition 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000012711 vitamin K3 Nutrition 0.000 description 1
- 239000011652 vitamin K3 Substances 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940041603 vitamin k 3 Drugs 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 229940005675 zinc oxide 5 mg Drugs 0.000 description 1
- 229910000859 α-Fe Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/06—Mixtures of whey with milk products or milk components
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/04—Whey; Whey preparations containing non-milk components as source of fats or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/08—Whey; Whey preparations containing other organic additives, e.g. vegetable or animal products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/10—Whey; Whey preparations containing inorganic additives
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Dairy Products (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses a kind of babies ' formula milk powder, which is made of the raw material of following mass fraction:Desalted whey 100,000 200000, skim milk 400,000 600000, plant oil powder 20,000 30000, lactose 50,000 55000, whey protein concentrate 6,000 10000, galactooligosaccharide 1,000 15000, linoleic acid 3,000 4000, alpha linolenic acid 400 500, arachidonic acid oil 70 90, docosahexaenoic acid grease 30 40, caseinhydrolysate 10,000 30000, taurine 40 50, nucleotide 20 30, choline 80 100, inositol 20 40, l-cn 79, vitamin combination 86 93 and minerals 851 956.Advantageous effect:Facilitate digestion, promote intestines peristalsis, promotes calcium absorption, improve the immune function of baby, contribute to the healthy growth of infant.
Description
Technical field
The present invention relates to technical field of dairy processing, it particularly relates to a kind of babies ' formula milk powder and preparation method thereof.
Background technology
After the baby formula milk powder humanized formula scientific and reasonable according to its is proposed as non-breastfeeding and wean
The important supplement food of infant growth, using the physiological knowledge of continuous development, Tiny ecosystem science makes formula milk
Quality constantly improves, and is allowed to be closer to the various functions of breast milk, exempt from comprising the natural prebiotic factor and activity in breast milk
Epidemic disease substance can promote the growth of nascent infant's intestinal beneficial flora, inhibit spoilage organisms, enhance immune function, and China is annual
There are about 17,000,000 baby dues, wherein having 80% can obtain breast milk, 20% is insufficient without breast milk or breast milk, there is nearly 3,400,000 baby
Youngster needs to use dispensed food for baby, and first three years of a baby's birth, is that it develops the most key stage in life, especially
The birth of the first 6 months, the ideal food of baby is breast milk, if breast milk is insufficient or because other reasons are unable to feeding breast milk
When, the formula milk of high-quality then becomes the first choice of baby's healthy development.
For the problems in the relevant technologies, currently no effective solution has been proposed.
Invention content
For the problems in the relevant technologies, a kind of babies ' formula milk powder of present invention proposition and preparation method thereof is existing to overcome
There is the above-mentioned technical problem present in the relevant technologies.
The technical proposal of the invention is realized in this way:
According to an aspect of the invention, there is provided a kind of babies ' formula milk powder.
The babies ' formula milk powder is made of the raw material of following mass fraction:
Desalted whey 100000-200000, skim milk 400000-600000, plant oil powder 20000-30000, lactose
50000-55000, whey protein concentrate 6000-10000, galactooligosaccharide 1000-15000, linoleic acid 3000-4000, α-are sub-
Numb acid 400-500, arachidonic acid oil 70-90, docosahexaenoic acid grease 30-40, caseinhydrolysate 10000-
30000, taurine 40-50, nucleotide 20-30, choline 80-100, inositol 20-40, l-cn 7-9, vitamin combination
86-93 and minerals 851-956.
Further, the plant oil powder includes following material component:Sunflower seeds oil powder 6000-10000, soybean oil powder
7000-10000 and vegetable seed oil powder 7000-10000.
Further, the nucleotide includes following material component:5'-monophosphate adenosine 4-6,5'-inosinic acid disodium 4-
6,5'-GMP2Na 4-6,5'-UMP disodium 4-6 and 5'-CMP disodium 4-6.
Further, the vitamin combination includes following material component:L-AA sodium 75-80, choline chloride
0.025-0.035, dl- alpha-tocopherol 0.01-0.02, niacinamide 0.5-0.6, retinol acetate 0.55-0.6, D-VB5 calcium
0.005-0.015, folic acid 0.1-0.11, D-Biotin 0.02-0.03, chlorocobalamin 0.015-0.02, thiamine hydrochloride 0.63-
0.7, Vitamin D3 0.005-0.01, riboflavin 1-1.1, puridoxine hydrochloride 0.4-0.5, phytondione 0.04-0.06, niacin
3.7-4.6 with pantothenic acid 4-4.6.
Further, the minerals include following material component:Calcium monohydrogen phosphate 300-330, magnesium chloride 30-35, burnt phosphorus
Sour iron 5-10, potassium chloride 400-450, zinc oxide 5-10, sodium chloride 110-120, potassium iodide 0.07-0.09, copper sulphate 0.37-
0.39, manganese sulfate 0.07-0.08 and sodium selenite 0.015-0.025.
According to another aspect of the present invention, a kind of preparation method of babies ' formula milk powder is provided.
The preparation method of the babies ' formula milk powder, includes the following steps:
According to above-mentioned mass fraction, raw material needed for the babies ' formula milk powder is weighed, and during weighing, by the original
Material injects in same container, and raw material is promoted to be mixed, and forms initial mixture;
The initial mixture is continuously stirred, the raw material is made to be sufficiently mixed, formation is sufficiently mixed object;
Sieving screening is carried out to the object that is sufficiently mixed by preconfigured screening machine, promotes described to be sufficiently mixed object
State is pulverulent mixture;
By preconfigured apparatus for separating metals, the object that is sufficiently mixed after being screened to sieving carries out postsearch screening, forms milk
Powder, and obtained milk powder is put into storage box store it is spare;
According to preassigned packing specification, the milk powder in storage box is extracted by auger and is injected into predetermined
Container is loaded.
Further, the preparation method of the babies ' formula milk powder, it is further comprising the steps of:
According to above-mentioned mass fraction, before weighing raw material needed for the babies ' formula milk powder, the raw material is taken
Sample detects, and in the case where sampling inspection results are up to standard, judges that material quality is qualified and let pass into next preparation
Step is sealed up for safekeeping conversely, carrying out isolation to raw material.
Further, the milk powder in storage box is extracted by auger and is injected into predetermined container and carry out filling packet
Include following steps:
Milk powder after auger is extracted is filled into preprepared surge tank;
Preprepared storage tank is carried out to emptying iron flask successively, is put into spoon and UV-V sterilization operations;
Storage tank is sent into preprepared filling bottle placer after sterilization, and sets filling dosage;
Mixture in surge tank is filling to after sterilizing in storage tank, and carry out sealed cans after protective gas is added;
Storage tank after sealed cans is subjected to cleaning treatment, and controls loading;
Storage tank after cleaning is subjected to spray bar code operation;
By storage tank packing and binding after coding, and carton is labelled;
Finished product after labeling is stored and is detected, and testing result is analyzed, is let pass if finished product is up to standard,
If finished product progress product not up to standard is sealed up for safekeeping;
Shipment is carried out to the finished product after clearance.
Wherein, material component of the present invention is described below:
Desalted whey:Whey powder main component is lactalbumin and lactose, and desalted whey powder is by the mineral in whey powder
Salt is sloughed, and for infant, content of mineral substances height can increase the kidney burden of baby, it is therefore necessary to slough minerals, and can
To adjust protein ratio, close to breast milk level.
Skim milk:Skim milk is that the fat of normal milk is removed a part, make fat content drop to 0.5% with
Under, it is less than 1/7th of ordinary milk fat mass.
Lactose:As the absorption dispersant of powdered food pigment, pigment concentration is reduced, is easy to use and reduces storage period
Discoloration make the excipient such as tabletting using the compressible forming feature low with water imbibition.
Whey protein concentrate:It is then dry that soluble powder is made using protein in hyperfiltration technique condensed whey, extensively
For food processing industry, such as ham, custard, candy, crab meat stick, cake, babies ' formula milk powder, sports drink, formula battalion
Support feed etc..
Galactooligosaccharide (GOS):Galactooligosaccharide is the beneficial bacteriums such as Bifidobacterium in human body intestinal canal, Lactobacillus acidophilus pole
Good nutrient source and effective proliferation factor can improve the digestion and absorption function of human body intestinal canal, promote intestines peristalsis, mitigation can
The excessive internal heat symptom of energy promotes intestinal health, promotes growth of probiotics, promotes calcium absorption.
Linoleic acid:Due to having the function of reducing cholesterol and blood fat in blood of human body, treatment Atherosclerosis can be used as
The raw material of chemical drug object.
Alpha-linolenic acid:Alpha-linolenic acid is the basic substance for constituting cell membrane and biological enzyme, and decisive work is played to health
With, alpha-linolenic acid be health it is required but general lack of being badly in need of a kind of essential nutrients of supplement.
Arachidonic acid (ARA) grease:It is that people's in-vivo content is abundant, a kind of most active and required long-chain unsaturated fat
Acid can be used as nutrition fortifier and be added in baby formula milk powder and food.
Docosahexaenoic acid (DHA) grease:It is commonly called as docosapentaenoic acid, is a kind of to the very important unsaturated fat of human body
Acid, DHA are a kind of main components of nervous system cell growth and maintenance, are the important composition ingredients of brain and retina,
Content is up to 20% in human brain cortex, proportion about 50% in eye retina, sends out tire infant intelligence and eyesight
It educates most important.
Caseinhydrolysate:Be mammal include main protein in cow, sheep and people's milk, also known as casein, casein,
Lactic casein.
Taurine:Utilization rate of the body to protein is improved, promotes the development of brain cell structure and function, taurine straight
It connects and participates in nerve cell macromolecular anabolism, promote brain nervous cell proliferation, differentiation, to infant's brain development, nerve
Conduction, perfect, calcium the absorption of visual function have good action.
Nucleotide:The immune function for improving baby, increases the absorption of iron, influences the metabolism of lipoprotein, improves intestinal beneficial
Flora improves function of intestinal canal and liver function.
5'-monophosphate adenosine:Also known as a phosphorus adenylate, a kind of nucleotide found in ribonucleic acid is a kind of phosphoric acid
And the ester of nucleosides adenosine, and by phosphate functional group, pentose nucleic acid sugar and bases adenine is formed and vitamin B8, one
Kind water soluble vitamin.
5'-inosinic acid disodium:It is colourless to white crystals or white crystalline powder, to protect it from the foods such as the flesh of fish
The decomposition of phosphate and its is made to play maximum flavor power in product.
5'-GMP2Na:It is colourless to white crystals or white crystalline powder, delicate flavour intensity is Sodium Inosinate
It is 2.3 times, non-hygroscopic with sodium glutamate and with there is very strong synergistic effect, it is dissolved in water, stabilized aqueous solution.
5'-UMP disodium:For white or off-white powder, production nucleic acid drug intermediate, health food can be used as
And biochemical reagents.
5'-CMP disodium:Flavoring agent is also used to supplement the nucleotide in cow's milk, to produce the breast milk close to human milk
Milk can enhance resistivity of the baby to bacteriosis.
Choline:A kind of strong organic base, is the constituent of lecithin, exists among sphingomyelin, is that body can
Become a source of methyl and act on the product of synthesizing methyl, while being the precursor of acetylcholine again, is converted in infants
For acetylcholine, enhance baby's memory.
Inositol:Inositol is widely distributed in animal and plant body, is that animal, the growth factor of microorganism and choline are common
The formation that the neuron and nerve synapse in area are remembered to infant brain plays a crucial role, and enhances the intelligence of baby and improves memory
Power.
L-cn:It assists baby to maintain normal body temperature, ensures the energy supply derived from fat, prevent baby's carnitine and lack
Disease.
Vitamin combination:It is the required micro-nutrient composition of organism, and can not be generally given birth to by organism oneself
Production needs to obtain by means such as diet, and vitamin cannot can generate energy as carbohydrate, protein and fat, form
Cell, but they play regulatory role the metabolism of organism.
L-AA sodium:It is pharmaceutically used for replenishing vitamins C, makes an addition in food and beverage and can be used for anti-oxidant, energy
It effectively prevent food and beverage to change colour, it is spoiled, therefore it is widely used in ham, sausage, the fresh-keeping fixation of breaded fish stick and moon cake, cake
It is mould proof, be added cosmetics in for wrinkle resistant, anti-aging, whitening.
Choline chloride:It can prevent the Fat Accumulation in liver, kidney and its tissue degeneratiaon;It can promote the group again of amino acid
It closes;Amino acid, the especially utilization rate of essential amino acid methionine in vivo can be improved.
Dl- alpha-tocopherols:The hydrolysate of vitamin E, is one of most important antioxidant, tocopherol can promotion property swash
Element secretion makes man's sperm motility and quantity increase;Woman's female hormone concentration is set to increase, raising fecundity, prevention of miscarriage,
It can also be used to prevent male sterility, burn, frostbite, capillary hemorrhage, climacteric syndrome, beauty etc..
Niacinamide:Niacinamide is a member in vitamin B complex, vitamin B3, and niacin can in vivo be converted into cigarette
Amide.
Retinol acetate:That is axerophtholum aceticum is able to maintain that human homergy, be able to maintain that cell membrane stabilization and
Development, the normal function for maintaining reproductive system.
D-VB5 calcium:It is the ingredient of coacetylase for medicine, food and feed additive, participates in carbohydrate, fat
With the metabolism of protein, it is clinically used for treatment Vitamin B deficiency disease, peripheral neuritis, postoperative intestine angina participates in albumen
Matter, fat, the metabolism of sugar in vivo.
Folic acid:One of vitamin B complex plays the role of promoting juvenile cell in marrow ripe, and the mankind can as lacked folic acid
Cause macrocytic anemia and leukopenia, is even more important to pregnant woman.
D-Biotin:Also known as biotin, biotin are water soluble vitamins, also belong to vitamin B race, B7, it is to close
It is fat and the indispensable substance of protein eubolism at ascorbic necessary material, is a kind of maintenance human body natural life
Long, development and the necessary nutrient of normal human's functional health.
Chlorocobalamin:The antidote of cyanide poisoning.
Thiamine hydrochloride:It is the hydrochloride of thiamines, is a kind of existence form of vitamin B1, nutritional supplement, vitamin
B1 participates in the intermediate supersession of carbohydrate in vivo.
Vitamin D3:Also known as vitamine D3 or cholecalciferol are one kind of vitamin D, are a kind of fat-soluble dimension lifes
Element is also regarded as a kind of hormone precursor acting on Ca,P metabolism.
Riboflavin:Be called vitamin B2, be internal yellow enzymes prothetic group component part (yellow enzyme is sent out in biological oxidation
Wave and pass hydrogen effect), when lacking, the biological oxidation of body is just influenced, makes metabolism that obstacle occur.Its lesion shows as mouth, eye more
With the inflammation at external genital organs position, such as angular stomatitis, cheilitis, glossitis, eye conjunctivitis and scrotitis.
Puridoxine hydrochloride:It is called crystallization or the crystalline powder of vitamin B6, white or off-white color, odorless, sour hardship, dimension
Raw element hardening agent, this product is many enzymes such as glutamic-pyruvic transaminase, decarboxylase, racemase, dehydrogenase, synzyme and hydroxylase etc. in body
Coenzyme, and the decomposition of carbohydrate and protein can be helped, utilized, there is the deficiency disease of similar niacin in when shortage, in addition vitamin B6
Also participate in the reaction that tryptophan converts niacin to serotonin.And the growth of leucocyte can be stimulated, it is to form hemoglobin institute
The substance needed.
Phytondione:Also known as vitamin K1 belongs to a kind of polycyclic aromatic ketone, is a kind of liposoluble vitamin, to sky
Gas and humidity are stablized, but can be decomposed in the sun, belong to vitamin medicaments, caused by being mainly used for various vitamin K deficiencies
The treatment of hemorrhagic disease.
Niacin:Niacin is also referred to as vitamin B3, niacin also known as niacin, antipellagra factor, further includes it in human body
Derivative niacinamide or niacinamide, it is one of 13 kinds of vitamin needed by human, is a kind of water soluble vitamin, belongs to dimension
Sheng Su B races.
Pantothenic acid:Also referred to as vitamin B5, pantothenic acid, odorless, mildly bitter flavor are stored in because of its property slant acidity and extensively a variety of foods
In object, so gain the name.The nutritional status of generally accepted pantothenic acid and hair, skin is closely related, when hair lacks gloss or becomes
It is supplement its visible effect of pantothenic acid when sparse more;It is also one of effect of pantothenic acid to manufacture antibody, and human body can be helped to resist infectious disease,
Multiple Classes of Antibiotics side effect and toxicity are mitigated, allergic symptom is mitigated, pantothenic acid shortage easily causes blood and skin abnormality, generates low blood
The diseases such as sugar.
Minerals:It is the compound or native element of naturally occurring in the earth's crust.Also known as inorganic salts are inorganic matters in human body
General name is the general name for constituting tissue and maintaining various elements necessary to normal physiological function, is Qi great Ying needed by human
One of element is supported, minerals and vitamins are the same, are that human body must required element.
Calcium monohydrogen phosphate:Make hardening agent (supplement calcium) and leavening agent, also can be used as quality improver, for Flour product of fermenting,
Appropriate use is needed by production, as food feed additive, to supplement the phosphorus in poultry and livestock feed, calcium constituent.
Magnesium chloride:Food additives, protein coagulation agent, deicing salt, refrigerant, dust-proofing agent, refractory material etc. can be done.
Ferric pyrophosphate:Make nutritional supplement (irony hardening agent) for food industry, be used for strengthening model, baby food and
Other normal foods.
Potassium chloride:In food service industry, it can be used as salt substitute applied to agricultural production, aquatic products, livestock products, fermentation, seasoning, tank
Head, instant food etc. make low Na prod, to reduce the excessively high harmful effect to body of sodium content.
Zinc oxide:Zinc oxide has application, including plastics, ceramics, glass, water as additive in multiple material and product
Mud, lubricant, paint, ointment, adhesive, sealant, pigment, food (zinc supplementation agent), battery, Ferrite Material, fire-retardant material
Material and first-aid bandage etc..
Sodium chloride:Sodium chloride is that people institute is indispensable, and the total amount of contained sodium ion is about 60g in adult body, wherein
80% is present in extracellular fluid, i.e., in blood plasma and intercellular fluid, chlorion is also primarily present in extracellular fluid, sodium ion and chlorine
The physiological function of ion mainly has:The osmotic pressure for maintaining extracellular fluid, participates in the adjusting of internal acid-base balance, chlorion is in vivo
The generation of hydrochloric acid in gastric juice is participated in, in addition, sodium chloride also has effect in the normal excitability for maintaining nerves and muscles.
Potassium iodide:For manufacturing organic compound and chemical reagent etc., potassium iodide also has antifungal activity.Clinic with it come
Sporotrichosis, chromoblastomycosis, persistent erythema nodosum and nodular vasculitis etc. are treated, is used to prevent in medicine
Control endemicgoiter, promote the absorption and eliminating the phlegm of vitreum muddiness, as photosensitive emulsifier, food additives,
The cosolvent of iodine and certain insoluble metal iodide.
Copper sulphate:For white or pale powder, aqueous solution is weakly acidic, shows blue, copper sulphate is to prepare other to contain
The important source material of copper compound can obtain Bordeaux mixture with milk of lime mixing, be used as fungicide.
Manganese sulfate:Manganese sulfate is the trace element that the crop of synthetic fatty acid needs, therefore manganese sulfate can be as fertilizer
It applies into soil, can increase production, manganese sulfate is added in animal feed, and it is also to prepare other manganese salts to have the effect of fattening, manganese sulfate
Raw material and analytical reagent.
Sodium selenite:Selenium is the component part of glutathione peroxidase, and the function of cell membrane is maintained by oxidation,
The yield for improving the endogenous antioxidant of the lipid nature of protein, participates in the conversion of energy, influences to be metabolized, to the breast of fat
Change, absorption and multivitamin absorption play an important role, while also participating in the synthesis with coacetylase, ubiquinone, shadow
The function of ringing other biological enzyme system, all has an impact the metabolism of amino acid, the synthesis of protein, carbohydate metabolism, biological oxidation.
Livestock and poultry body selenium deficiency can seriously affect growth and development and the reproductive capability of livestock and poultry.
Beneficial effects of the present invention are:By adding lactalbumin, so that babies ' formula milk powder is closer to breast milk, more
Add and facilitates digestion;By adding docosahexaenoic acid grease and arachidonic acid oil, to promote central nervous system, with
And the development growth of brain and retina;Mitigate possible excessive internal heat disease by adding galactooligosaccharide to promote intestines peristalsis
Shape promotes intestinal health, promotes growth of probiotics, promotes calcium absorption;By adding nucleotide, to improve the immune of baby
Function increases the absorption of iron, influences the metabolism of lipoprotein, improves intestinal beneficial flora, improves function of intestinal canal and liver function;Pass through
Taurine is added, to improve utilization rate of the body to protein, promotes the development of brain cell structure and function, taurine straight
It connects and participates in nerve cell macromolecular anabolism, promote brain nervous cell proliferation, differentiation, to infant's brain development, nerve
Conduction, perfect, calcium the absorption of visual function have good action;By adding choline, so that choline turns in infants
Acetylcholine is turned to, enhancing baby's memory is by adding inositol, so that inositol and choline jointly remember infant brain
The formation of the neuron and nerve synapse in area plays a crucial role, and enhances the intelligence of baby and improves memory;It is left-handed by adding
Carnitine ensures the energy supply derived from fat so that l-cn assists baby to maintain normal body temperature, prevents baby's carnitine
Deficiency disease;The present invention uses Hyposmolality formula, prevents as caused by enteron aisle hyperosmosis environment electrolyte disturbance and caused
Baby material absorbing it is disorderly, the amount of electrolyte and non-electrolyte class solute particles phosphorus, sodium, potassium, chlorine plasma is controlled in baby
The level that child can rationally utilize, and phosphorus content is higher, is since calcium phosphorus ration influences the absorption of calcium.Simultaneously for China
The characteristics of infant's easy calcium deficiency, the content of calcium increased with respect to breast milk in formula, so the content that improve phosphorus reaches most suitable
Suitable calcium uptake utilizes level.Therefore, the content of ashes reduced in baby milk powder is that baby milk powder manufacturing enterprise is most important
One of scientific and technical research, so Hyposmolality formula milk contributes to the healthy growth of infant.
Description of the drawings
It in order to more clearly explain the embodiment of the invention or the technical proposal in the existing technology, below will be to institute in embodiment
Attached drawing to be used is needed to be briefly described, it should be apparent that, the accompanying drawings in the following description is only some implementations of the present invention
Example, for those of ordinary skill in the art, without creative efforts, can also obtain according to these attached drawings
Obtain other attached drawings.
Fig. 1 is a kind of one of the preparation method flow chart of babies ' formula milk powder according to the ... of the embodiment of the present invention;
Fig. 2 is the two of the preparation method flow chart of a kind of babies ' formula milk powder according to the ... of the embodiment of the present invention.
Specific implementation mode
Following will be combined with the drawings in the embodiments of the present invention, and technical solution in the embodiment of the present invention carries out clear, complete
Site preparation describes, it is clear that described embodiments are only a part of the embodiments of the present invention, instead of all the embodiments.It is based on
Embodiment in the present invention, the every other embodiment that those of ordinary skill in the art are obtained belong to what the present invention protected
Range.
According to an embodiment of the invention, a kind of babies ' formula milk powder is provided.
Babies ' formula milk powder according to the ... of the embodiment of the present invention, the babies ' formula milk powder by following mass fraction raw material system
At:
Desalted whey 100000-200000, skim milk 400000-600000, plant oil powder 20000-30000, lactose
50000-55000, whey protein concentrate 6000-10000, galactooligosaccharide 1000-15000, linoleic acid 3000-4000, α-are sub-
Numb acid 400-500, arachidonic acid oil 70-90, docosahexaenoic acid grease 30-40, caseinhydrolysate 10000-
30000, taurine 40-50, nucleotide 20-30, choline 80-100, inositol 20-40, l-cn 7-9, vitamin combination
86-93 and minerals 851-956.
Wherein, the plant oil powder includes following material component:Sunflower seeds oil powder 6000-10000, soybean oil powder 7000-
10000 and vegetable seed oil powder 7000-10000.
The nucleotide includes following material component:5'-monophosphate adenosine 4-6,5'-inosinic acid disodium 4-6,5 '-guanosines
Acid disodium 4-6,5'-UMP disodium 4-6 and 5'-CMP disodium 4-6.
The vitamin combination includes following material component:L-AA sodium 75-80, choline chloride 0.025-
0.035, dl- alpha-tocopherols 0.01-0.02, niacinamide 0.5-0.6, retinol acetate 0.55-0.6, D- calcium pantothenate 0.005-
0.015, folic acid 0.1-0.11, D-Biotin 0.02-0.03, chlorocobalamin 0.015-0.02, thiamine hydrochloride 0.63-0.7, courage calcium
Change alcohol 0.005-0.01, riboflavin 1-1.1, puridoxine hydrochloride 0.4-0.5, phytondione 0.04-0.06, niacin 3.7-4.6
With pantothenic acid 4-4.6.
The minerals include following material component:Calcium monohydrogen phosphate 300-330, magnesium chloride 30-35, ferric pyrophosphate 5-10,
Potassium chloride 400-450, zinc oxide 5-10, sodium chloride 110-120, potassium iodide 0.07-0.09, copper sulphate 0.37-0.39, manganese sulfate
0.07-0.08 and sodium selenite 0.015-0.025.
For the clearer above-mentioned technical proposal for understanding the present invention, below by way of specific example to the above-mentioned side of the present invention
Case is described in detail.
Embodiment one
A kind of babies ' formula milk powder, the babies ' formula milk powder are made of the raw material of following mass fraction:
Desalted whey 100000mg, skim milk 400000mg, plant oil powder 20000mg, lactose 50000mg, concentrated milk
Albumin 6000mg, galactooligosaccharide 1000mg, linoleic acid 3000mg, α-leukotrienes 400mg, arachidonic acid oil 70mg,
Docosahexaenoic acid grease 30mg, caseinhydrolysate 10000mg, taurine 40mg, nucleotide 20mg, choline 80mg, inositol
20mg, l-cn 7mg, vitamin combination 86mg and minerals 851mg.
Wherein, the plant oil powder includes following material component:Sunflower seeds oil powder 6000mg, soybean oil powder 7000mg and
Vegetable seed oil powder 7000mg.
The nucleotide includes following material component:5'-monophosphate adenosine 4mg, 5'-inosinic acid disodium 4mg, 5 '-guanosines
Acid disodium 4mg, 5'-UMP disodium 4mg and 5'-CMP disodium 4mg.
The vitamin combination includes following material component:L-AA sodium 75mg, choline chloride 0.025mg,
Dl- alpha-tocopherols 0.01mg, niacinamide 0.5mg, retinol acetate 0.55mg, D-VB5 calcium 0.005mg, folic acid 0.1mg, D-
Biotin 0.02mg, chlorocobalamin 0.015mg, thiamine hydrochloride 0.63mg, Vitamin D3 0.005mg, riboflavin 1mg, hydrochloric acid pyrrole
Tremble alcohol 0.4mg, phytondione 0.04mg, niacin 3.7mg and pantothenic acid 4mg.
The minerals include following material component:Calcium monohydrogen phosphate 300mg, magnesium chloride 30mg, ferric pyrophosphate 5mg, chlorination
Potassium 400mg, zinc oxide 5mg, sodium chloride 110mg, potassium iodide 0.07mg, copper sulphate 0.37mg, manganese sulfate 0.07mg and selenous acid
Sodium 0.015mg.
The preparation of the babies ' formula milk powder, includes the following steps:
According to above-mentioned mass fraction, raw material desalted whey 100000mg, degreasing ox needed for the babies ' formula milk powder are weighed
Milk 400000mg, lactose 50000mg, whey protein concentrate 6000mg, galactooligosaccharide 1000mg, linoleic acid 3000mg, α-are sub-
Numb acid 400mg, arachidonic acid oil 70mg, docosahexaenoic acid grease 30mg, caseinhydrolysate 10000mg, taurine
40mg, choline 80mg, inositol 20mg, l-cn 7mg, sunflower seeds oil powder 6000mg, soybean oil powder 7000mg, vegetable seed oil powder
7000mg, 5'-monophosphate adenosine 4mg, 5'-inosinic acid disodium 4mg, 5'-GMP2Na 4mg, 5'-UMP disodium 4mg,
5'-CMP disodium 4mg, L-AA sodium 75mg, choline chloride 0.025mg, dl- alpha-tocopherol 0.01mg, niacinamide
0.5mg, retinol acetate 0.55mg, D-VB5 calcium 0.005mg, folic acid 0.1mg, D-Biotin 0.02mg, chlorocobalamin
0.015mg, thiamine hydrochloride 0.63mg, Vitamin D3 0.005mg, riboflavin 1mg, puridoxine hydrochloride 0.4mg, phytondione
0.04mg, niacin 3.7mg, pantothenic acid 4mg, calcium monohydrogen phosphate 300mg, magnesium chloride 30mg, ferric pyrophosphate 5mg, potassium chloride 400mg, oxygen
Change zinc 5mg, sodium chloride 110mg, potassium iodide 0.07mg, copper sulphate 0.37mg, manganese sulfate 0.07mg and sodium selenite 0.015mg,
And during weighing, above-mentioned raw materials are injected in same container, raw material is promoted to be mixed, forms initial mixture;
The initial mixture is continuously stirred, the raw material is made to be sufficiently mixed, formation is sufficiently mixed object;
Sieving screening is carried out to the object that is sufficiently mixed by preconfigured screening machine, promotes described to be sufficiently mixed object
State is pulverulent mixture;
By preconfigured apparatus for separating metals, the object that is sufficiently mixed after being screened to sieving carries out postsearch screening, forms milk
Powder, and obtained milk powder is put into storage box store it is spare;
According to preassigned packing specification, the milk powder in storage box is extracted by auger and is injected into predetermined
Container is loaded.
Embodiment two
A kind of babies ' formula milk powder, the babies ' formula milk powder are made of the raw material of following mass fraction:
Desalted whey 150000mg, skim milk 500000mg, plant oil powder 24000mg, lactose 53000mg, concentrated milk
Albumin 8000mg, galactooligosaccharide 1200mg, linoleic acid 3500m g, α-leukotrienes 450mg, arachidonic acid oil
80mg, docosahexaenoic acid grease 35mg, caseinhydrolysate 20000mg, taurine 45mg, nucleotide 25mg, choline 90mg,
Inositol 30mg, l-cn 8mg, vitamin combination 90mg and minerals 905mg.
Wherein, the plant oil powder includes following material component:Sunflower seeds oil powder 8000mg, soybean oil powder 8000mg and
Vegetable seed oil powder 8000mg;
The nucleotide includes following material component:5'-monophosphate adenosine 5mg, 5'-inosinic acid disodium 5mg, 5 '-guanosines
Acid disodium 5mg, 5'-UMP disodium 5mg and 5'-CMP disodium 5mg;
The vitamin combination includes following material component:L-AA sodium 78mg, choline chloride 0.03mg, dl-
Alpha-tocopherol 0.015mg, niacinamide 0.55mg, retinol acetate 0.58mg, D-VB5 calcium 0.01mg, folic acid 0.105mg, D- life
Object element 0.025mg, chlorocobalamin 0.018mg, thiamine hydrochloride 0.660mg, Vitamin D3 0.007mg, riboflavin 1.05mg, salt
Sour pyridoxol 0.450mg, phytondione 0.05mg, niacin 4mg and pantothenic acid 4.3mg;
The minerals include following material component:Calcium monohydrogen phosphate 315mg, magnesium chloride 33mg, ferric pyrophosphate 8mg, chlorination
K42 5mg, zinc oxide 8mg, sodium chloride 115mg, potassium iodide 0.08mg, copper sulphate 0.38mg, manganese sulfate 0.075mg and selenous acid
Sodium 0.02m g.
The preparation of the babies ' formula milk powder, includes the following steps:
According to above-mentioned mass fraction, raw material desalted whey 150000mg, degreasing ox needed for the babies ' formula milk powder are weighed
Milk 500000mg, lactose 53000mg, whey protein concentrate 8000mg, galactooligosaccharide 1200mg, linoleic acid 3500m g, α-
Leukotrienes 450mg, arachidonic acid oil 80mg, docosahexaenoic acid grease 35mg, caseinhydrolysate 20000mg, ox sulphur
Sour 45mg, choline 90mg, inositol 30mg, l-cn 8mg, sunflower seeds oil powder 8000mg, soybean oil powder 8000mg, rapeseed oil
Powder 8000mg, 5'-monophosphate adenosine 5mg, 5'-inosinic acid disodium 5mg, 5'-GMP2Na 5mg, 5'-UMP disodium
5mg, 5'-CMP disodium 5mg, L-AA sodium 78mg, choline chloride 0.03mg, dl- alpha-tocopherol 0.015mg, nicotinoyl
Amine 0.55mg, retinol acetate 0.58mg, D-VB5 calcium 0.01mg, folic acid 0.105mg, D-Biotin 0.025mg, chlorocobalamin
0.018mg, it thiamine hydrochloride 0.660mg, Vitamin D3 0.007mg, riboflavin 1.05mg, puridoxine hydrochloride 0.450mg, plants
Object menadione 0.05mg, niacin 4mg, pantothenic acid 4.3mg, calcium monohydrogen phosphate 315mg, magnesium chloride 33mg, ferric pyrophosphate 8mg, potassium chloride
425mg, zinc oxide 8mg, sodium chloride 115mg, potassium iodide 0.08mg, copper sulphate 0.38mg, manganese sulfate 0.075mg and sodium selenite
0.02mg, and during weighing, above-mentioned raw materials are injected in same container, raw material is promoted to be mixed, form preliminary mixing
Object;
The initial mixture is continuously stirred, the raw material is made to be sufficiently mixed, formation is sufficiently mixed object;
Sieving screening is carried out to the object that is sufficiently mixed by preconfigured screening machine, promotes described to be sufficiently mixed object
State is pulverulent mixture;
By preconfigured apparatus for separating metals, the object that is sufficiently mixed after being screened to sieving carries out postsearch screening, forms milk
Powder, and obtained milk powder is put into storage box store it is spare;
According to preassigned packing specification, the milk powder in storage box is extracted by auger and is injected into predetermined
Container is loaded.
Embodiment three
A kind of babies ' formula milk powder, the babies ' formula milk powder are made of the raw material of following mass fraction:
Desalted whey 200000mg, skim milk 600000mg, plant oil powder 30000mg, lactose 55000mg, concentrated milk
Albumin 10000mg, galactooligosaccharide 15000mg, linoleic acid 4000mg, alpha-linolenic acid 500mg, arachidonic acid oil
90mg, docosahexaenoic acid grease 40mg, caseinhydrolysate 30000mg, taurine 50mg, nucleotide 30mg, choline
100mg, inositol 40mg, l-cn 9mg, vitamin combination 93mg and minerals 956mg.
Wherein, the plant oil powder includes following material component:Sunflower seeds oil powder 10000mg, soybean oil powder 10000mg
With vegetable seed oil powder 10000mg.
The nucleotide includes following material component:5'-monophosphate adenosine 6mg, 5'-inosinic acid disodium 6mg, 5 '-guanosines
Acid disodium 6mg, 5'-UMP disodium 6mg and 5'-CMP disodium 6mg.
The vitamin combination includes following material component:L-AA sodium 80mg, choline chloride 0.035mg,
Dl- alpha-tocopherols 0.02mg, niacinamide 0.6mg, retinol acetate 0.6mg, D-VB5 calcium 0.015mg, folic acid 0.11mg, D-
Biotin 0.03mg, chlorocobalamin 0.02mg, thiamine hydrochloride 0.7mg, Vitamin D3 0.01mg, riboflavin 1.1mg, hydrochloric acid pyrrole are trembled
Alcohol 0.5mg, phytondione 0.06mg, niacin 4.6mg and pantothenic acid 4.6mg.
The minerals include following material component:Calcium monohydrogen phosphate 330mg, magnesium chloride 35mg, ferric pyrophosphate 10mg, chlorination
Potassium 450mg, zinc oxide 10mg, sodium chloride 120mg, potassium iodide 0.09mg, copper sulphate 0.39mg, manganese sulfate 0.08mg and selenous acid
Sodium 0.025mg.
The preparation of the babies ' formula milk powder, includes the following steps:
According to above-mentioned mass fraction, raw material desalted whey 200000mg, degreasing ox needed for the babies ' formula milk powder are weighed
Milk 600000mg, lactose 55000mg, whey protein concentrate 10000mg, galactooligosaccharide 15000mg, linoleic acid 4000mg, α-
Leukotrienes 500mg, arachidonic acid oil 90mg, docosahexaenoic acid grease 40mg, caseinhydrolysate 30000mg, ox sulphur
Sour 50mg, choline 100mg, inositol 40mg, l-cn 9mg, sunflower seeds oil powder 10000mg, soybean oil powder 10000mg, vegetable seed
Oil powder 10000mg, 5'-monophosphate adenosine 6mg, 5'-inosinic acid disodium 6mg, 5'-GMP2Na 6mg, 5'-UMP two
Sodium 6mg, 5'-CMP disodium 6mg, the vitamin combination include following material component:L-AA sodium 80mg, chlorination
Choline 0.035mg, dl- alpha-tocopherol 0.02mg, niacinamide 0.6mg, retinol acetate 0.6mg, D-VB5 calcium 0.015mg, leaf
Sour 0.11mg, D-Biotin 0.03mg, chlorocobalamin 0.02mg, thiamine hydrochloride 0.7mg, Vitamin D3 0.01mg, riboflavin
1.1mg, puridoxine hydrochloride 0.5mg, phytondione 0.06mg, niacin 4.6mg, pantothenic acid 4.6mg, calcium monohydrogen phosphate 330mg, chlorination
Magnesium 35mg, ferric pyrophosphate 10mg, potassium chloride 450mg, zinc oxide 10mg, sodium chloride 120mg, potassium iodide 0.09mg, copper sulphate
0.39mg, manganese sulfate 0.08mg and sodium selenite 0.025mg, and during weighing, above-mentioned raw materials are injected in same container,
Promote raw material to be mixed, forms initial mixture;
The initial mixture is continuously stirred, the raw material is made to be sufficiently mixed, formation is sufficiently mixed object;
Sieving screening is carried out to the object that is sufficiently mixed by preconfigured screening machine, promotes described to be sufficiently mixed object
State is pulverulent mixture;
By preconfigured apparatus for separating metals, the object that is sufficiently mixed after being screened to sieving carries out postsearch screening, forms milk
Powder, and obtained milk powder is put into storage box store it is spare;
According to preassigned packing specification, the milk powder in storage box is extracted by auger and is injected into predetermined
Container is loaded.
In order to facilitate the above-mentioned technical proposal of the present invention is understood, below in conjunction with attached drawing to the flow of the said program of the present invention
It is described in detail, it is specific as follows:
According to an embodiment of the invention, a kind of preparation method of babies ' formula milk powder is additionally provided.
As shown in Figure 1, in the actual production process, the preparation of the babies ' formula milk powder includes the following steps:
Step S101 weighs raw material needed for the babies ' formula milk powder, and weighing process according to above-mentioned mass fraction
In, the raw material is injected in same container, raw material is promoted to be mixed, forms initial mixture;
In preliminary mixing, at 55-60 DEG C, pressure is controlled in 15-20MPa for temperature control;
Step S103 continuously stirs the initial mixture, so that the raw material is sufficiently mixed, formation is sufficiently mixed
Object;
Step S105 carries out sieving screening by preconfigured screening machine to the object that is sufficiently mixed, and promotes described fill
It is pulverulent mixture to divide the state of mixture;
Step S107, by preconfigured apparatus for separating metals, the object that is sufficiently mixed after being screened to sieving carries out secondary sieve
Choosing forms milk powder, and obtained milk powder is put into storage box store it is spare;
Step S109 extracts simultaneously the milk powder in storage box by auger according to preassigned packing specification
Predetermined container is injected into be loaded.
In one embodiment, the preparation of the baby milk, it is further comprising the steps of:
According to above-mentioned mass fraction, before weighing raw material needed for the babies ' formula milk powder, the raw material is taken
Sample detects, and in the case where sampling inspection results are up to standard, judges that material quality is qualified and let pass into next preparation
Step is sealed up for safekeeping conversely, carrying out isolation to raw material.
In one embodiment, as shown in Fig. 2, being extracted and being injected into pre- to the milk powder in storage box by auger
Constant volume device carries out filling and includes the following steps:
Step S201, the milk powder after auger is extracted are filled into preprepared surge tank;
Preprepared storage tank is carried out emptying iron flask, is put into spoon and UV-V sterilization behaviour by step S203 successively
Make;
Step S205, storage tank is sent into preprepared filling bottle placer after sterilization, and sets filling dosage;
Step S207, the mixture in surge tank is filling to after sterilizing in storage tank, and carried out after protective gas is added
Sealed cans;
Storage tank after sealed cans is carried out cleaning treatment, and controls loading by step S209;
Storage tank after cleaning is carried out spray bar code operation by step S211;
Step S213 by storage tank packing and binding after coding, and labels carton;
Step S215 is stored and is detected to the finished product after labeling, and analyzed testing result, if finished product is up to standard
It lets pass, if finished product progress product not up to standard is sealed up for safekeeping;
Step S217 carries out shipment to the finished product after clearance.
In conclusion by means of the above-mentioned technical proposal of the present invention, by adding lactalbumin, so that infant formula
Milk powder is closer to breast milk, more convenient digestion;By adding docosahexaenoic acid grease and arachidonic acid oil, to promote
Into central nervous system and the development growth of brain and retina;By adding galactooligosaccharide, to promote enteron aisle compacted
It is dynamic, mitigate possible excessive internal heat symptom, promote intestinal health, promote growth of probiotics, promotes calcium absorption;By adding nucleosides
Acid increases the absorption of iron to improve the immune function of baby, influences the metabolism of lipoprotein, improves intestinal beneficial flora, perfect
Function of intestinal canal and liver function;By adding taurine, to improve utilization rate of the body to protein, promote brain cell structure
With the development of function, taurine directly participates in nerve cell macromolecular anabolism, promotes brain nervous cell proliferation, differentiation,
There is good action to perfect, calcium the absorption of infant's brain development, nerve conduction, visual function;By adding choline, to
So that choline is converted into acetylcholine in infants, enhancing baby's memory is by adding inositol, so that inositol and courage
The formation that alkali jointly remembers infant brain the neuron and nerve synapse in area plays a crucial role, and enhances the intelligence of baby and raising
Memory;By adding l-cn, so that l-cn assists baby to maintain normal body temperature, ensure the energy derived from fat
Amount supply, prevents baby's carntine deficiency;The present invention uses Hyposmolality formula, prevents as caused by enteron aisle hyperosmosis environment
Electrolyte disturbance and caused baby's material absorbing are disorderly, by electrolyte and non-electrolyte class solute particles phosphorus, sodium, potassium, chlorine
The amount of plasma controls the level that can be rationally utilized in infant, and phosphorus content is higher, is since calcium phosphorus ration influences calcium
It absorbs.Simultaneously the characteristics of calcium deficiency easy for Chinese Infant and Children, the content of calcium increased with respect to breast milk in formula, so to improve
The content of phosphorus reaches optimum calcium uptake using level.Therefore, the content of ashes reduced in baby milk powder is baby milk powder
One of most important scientific and technical research of manufacturing enterprise, so Hyposmolality formula milk contributes to the healthy growth of infant.
The foregoing is merely illustrative of the preferred embodiments of the present invention, is not intended to limit the invention, all essences in the present invention
With within principle, any modification, equivalent replacement, improvement and so on should all be included in the protection scope of the present invention god.
Claims (8)
1. a kind of babies ' formula milk powder, which is characterized in that the babies ' formula milk powder is made of the raw material of following mass fraction:
Desalted whey 100000-200000, skim milk 400000-600000, plant oil powder 20000-30000, lactose
50000-55000, whey protein concentrate 6000-10000, galactooligosaccharide 1000-15000, linoleic acid 3000-4000, α-are sub-
Numb acid 400-500, arachidonic acid oil 70-90, docosahexaenoic acid grease 30-40, caseinhydrolysate 10000-
30000, taurine 40-50, nucleotide 20-30, choline 80-100, inositol 20-40, l-cn 7-9, vitamin combination
86-93 and minerals 851-956.
2. babies ' formula milk powder according to claim 1, which is characterized in that the plant oil powder includes following raw material group
Part:Sunflower seeds oil powder 6000-10000, soybean oil powder 7000-10000 and vegetable seed oil powder 7000-10000.
3. babies ' formula milk powder according to claim 2, which is characterized in that the nucleotide includes following material component:
5'-monophosphate adenosine 4-6,5'-inosinic acid disodium 4-6,5'-GMP2Na 4-6,5'-UMP disodium 4-6 and 5 '-cytidine
Acid disodium 4-6.
4. babies ' formula milk powder according to claim 3, which is characterized in that the vitamin combination includes following raw material
Component:L-AA sodium 75-80, choline chloride 0.025-0.035, dl- alpha-tocopherol 0.01-0.02, niacinamide 0.5-
0.6, retinol acetate 0.55-0.6, D-VB5 calcium 0.005-0.015, folic acid 0.1-0.11, D-Biotin 0.02-0.03, chlorine
Cobalt amine 0.015-0.02, thiamine hydrochloride 0.63-0.7, Vitamin D3 0.005-0.01, riboflavin 1-1.1, puridoxine hydrochloride
0.4-0.5, phytondione 0.04-0.06, niacin 3.7-4.6 and pantothenic acid 4-4.6.
5. babies ' formula milk powder according to claim 4, which is characterized in that the minerals include following material component:
Calcium monohydrogen phosphate 300-330, magnesium chloride 30-35, ferric pyrophosphate 5-10, potassium chloride 400-450, zinc oxide 5-10, sodium chloride 110-
120, potassium iodide 0.07-0.09, copper sulphate 0.37-0.39, manganese sulfate 0.07-0.08 and sodium selenite 0.015-0.025.
6. a kind of preparation method of babies ' formula milk powder, which is characterized in that for the babies ' formula milk powder described in claim 5
It prepares, includes the following steps:
According to above-mentioned mass fraction, raw material needed for the babies ' formula milk powder is weighed, and during weighing, the raw material is noted
Enter in same container, raw material is promoted to be mixed, forms initial mixture;
The initial mixture is continuously stirred, the raw material is made to be sufficiently mixed, formation is sufficiently mixed object;
Sieving screening is carried out to the object that is sufficiently mixed by preconfigured screening machine, promotes the state for being sufficiently mixed object
For pulverulent mixture;
By preconfigured apparatus for separating metals, the object that is sufficiently mixed after being screened to sieving carries out postsearch screening, forms milk powder, and
Obtained milk powder is put into storage box store it is spare;
According to preassigned packing specification, the milk powder in storage box is extracted by auger and is injected into predetermined container
It is loaded.
7. the preparation method of babies ' formula milk powder according to claim 6, which is characterized in that further comprising the steps of:
According to above-mentioned mass fraction, before weighing raw material needed for the babies ' formula milk powder, inspection is sampled to the raw material
It surveys, and in the case where sampling inspection results are up to standard, judge that material quality is qualified and let pass into next preparation process,
It is sealed up for safekeeping conversely, carrying out isolation to raw material.
8. the preparation method of babies ' formula milk powder according to claim 6, which is characterized in that by auger to storage box
In milk powder extract and be injected into predetermined container carry out filling include the following steps:
Milk powder after auger is extracted is filled into preprepared surge tank;
Preprepared storage tank is carried out to emptying iron flask successively, is put into spoon and UV-V sterilization operations;
Storage tank is sent into preprepared filling bottle placer after sterilization, and sets filling dosage;
Mixture in surge tank is filling to after sterilizing in storage tank, and carry out sealed cans after protective gas is added;
Storage tank after sealed cans is subjected to cleaning treatment, and controls loading;
Storage tank after cleaning is subjected to spray bar code operation;
By storage tank packing and binding after coding, and carton is labelled;
Finished product after labeling is stored and detected, and testing result is analyzed, is let pass if finished product is up to standard, if at
Product progress product not up to standard is sealed up for safekeeping;
Shipment is carried out to the finished product after clearance.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810370460.1A CN108651634A (en) | 2018-04-24 | 2018-04-24 | A kind of formula milk and preparation method thereof being suitble to 0 to 6 months babies |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810370460.1A CN108651634A (en) | 2018-04-24 | 2018-04-24 | A kind of formula milk and preparation method thereof being suitble to 0 to 6 months babies |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108651634A true CN108651634A (en) | 2018-10-16 |
Family
ID=63780095
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810370460.1A Pending CN108651634A (en) | 2018-04-24 | 2018-04-24 | A kind of formula milk and preparation method thereof being suitble to 0 to 6 months babies |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108651634A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109527313A (en) * | 2018-12-18 | 2019-03-29 | 西藏民族大学 | A kind of functional beverage and preparation method thereof can be relieved vision and physical fatigue |
CN110574866A (en) * | 2019-10-12 | 2019-12-17 | 城口县土行生农业科技发展有限公司 | Colorful vegetable and fruit noodles and making method thereof |
CN110999984A (en) * | 2019-12-24 | 2020-04-14 | 石家庄君乐宝乳业有限公司 | Hypoallergenic infant formula milk powder and preparation method thereof |
CN112316094A (en) * | 2020-12-30 | 2021-02-05 | 李桥梁 | Male lymph health-care essential oil and preparation method thereof |
CN118415243A (en) * | 2024-07-05 | 2024-08-02 | 内蒙古伊利实业集团股份有限公司 | Nutritional composition capable of improving bioavailability of aromatic amino acid and application thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104206539A (en) * | 2014-08-14 | 2014-12-17 | 澳优乳业(中国)有限公司 | Probiotic-containing infant milk powder |
CN104222313A (en) * | 2013-06-24 | 2014-12-24 | 北安宜品努卡乳业有限公司 | Milk powder with intelligence improving formula |
CN104757123A (en) * | 2015-04-03 | 2015-07-08 | 长沙素加营养品有限公司 | Full dry-mixing infant formula milk powder and preparation method of full dry-mixing infant formula milk powder |
CN106509130A (en) * | 2016-11-14 | 2017-03-22 | 光明乳业股份有限公司 | Hypoallergenic newborn formula milk powder and preparation method thereof |
-
2018
- 2018-04-24 CN CN201810370460.1A patent/CN108651634A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104222313A (en) * | 2013-06-24 | 2014-12-24 | 北安宜品努卡乳业有限公司 | Milk powder with intelligence improving formula |
CN104206539A (en) * | 2014-08-14 | 2014-12-17 | 澳优乳业(中国)有限公司 | Probiotic-containing infant milk powder |
CN104757123A (en) * | 2015-04-03 | 2015-07-08 | 长沙素加营养品有限公司 | Full dry-mixing infant formula milk powder and preparation method of full dry-mixing infant formula milk powder |
CN106509130A (en) * | 2016-11-14 | 2017-03-22 | 光明乳业股份有限公司 | Hypoallergenic newborn formula milk powder and preparation method thereof |
Non-Patent Citations (2)
Title |
---|
陈炳卿: "《营养与食品卫生》", 31 May 2000, 人民卫生出版社 * |
顾世光等: "《生殖健康》", 30 June 1998, 人民卫生出版社 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109527313A (en) * | 2018-12-18 | 2019-03-29 | 西藏民族大学 | A kind of functional beverage and preparation method thereof can be relieved vision and physical fatigue |
CN110574866A (en) * | 2019-10-12 | 2019-12-17 | 城口县土行生农业科技发展有限公司 | Colorful vegetable and fruit noodles and making method thereof |
CN110999984A (en) * | 2019-12-24 | 2020-04-14 | 石家庄君乐宝乳业有限公司 | Hypoallergenic infant formula milk powder and preparation method thereof |
CN112316094A (en) * | 2020-12-30 | 2021-02-05 | 李桥梁 | Male lymph health-care essential oil and preparation method thereof |
CN118415243A (en) * | 2024-07-05 | 2024-08-02 | 内蒙古伊利实业集团股份有限公司 | Nutritional composition capable of improving bioavailability of aromatic amino acid and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108651634A (en) | A kind of formula milk and preparation method thereof being suitble to 0 to 6 months babies | |
US7674490B2 (en) | Food and vitamin preparations containing the natural isomer of reduced folates | |
CN102325468B (en) | It is the nutritious supplementary pharmaceutical of more than 50 years old individual raising vigor, immunity, eye and bone health | |
US10702496B2 (en) | Method of using a composition for enhancing newborn infant cognitive, brain and/or CNS development | |
CN109527313A (en) | A kind of functional beverage and preparation method thereof can be relieved vision and physical fatigue | |
JP2021045135A (en) | Oral delivery product | |
KR101171068B1 (en) | Pharmaceutical Compositions for Diabetes Improvement and Prevention Containing Mineral Compositions as Effective Component | |
JP2014131961A (en) | Animal nutrient composition | |
CN110604218A (en) | Formula and preparation method of pet nutrition paste | |
RU2390271C1 (en) | Preparation for increasing of organism adaptability to extreme conditions | |
CN110584120A (en) | Bone health composition | |
CN108850198A (en) | A kind of suitable 6-12 month babies ' formula milk powders and preparation method thereof | |
CN108740019A (en) | A kind of formula milk and preparation method thereof of suitable 12-36 months child | |
CN106036387A (en) | Super chenopodium quinoa willd nutritional packet for promoting growth of children | |
CN105995119A (en) | High-copper feed for establishing HLD (hepatolenticular degeneration) animal model and preparation method of high-copper feed | |
CN105533699A (en) | Compound for supplementing zinc and vitamin in children as well as preparation method and application thereof | |
US6645519B2 (en) | Method for producing taurine-enriched milk | |
RU2533913C1 (en) | Method for fruits and berries complex enrichment with selenium, iodine, zinc, magnesium and manganese | |
CN106417175A (en) | Method for producing eggs containing low cholesterol and rich magnesium and vitamin A | |
CN107616505B (en) | A health product containing ornithine ketoglutarate and its preparation method | |
KR20170065877A (en) | Liquid composition of health functional food containing vitamin D and zinc | |
CN112868796A (en) | Infant formula goat milk powder and preparation method thereof | |
JPH10273442A (en) | Bone metabolic improvement drug and nutritive composition | |
EP4072515A1 (en) | Combination product contributing to the well-being of pregnant women, comprising epa, dha, vitamins and minerals | |
CN107772459A (en) | A kind of formula powder for maple syrup urine disease and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181016 |